Latest / Birmingham AL News Today | 2 Min News | The Daily News Now!
BioCryst Cuts Internal Discovery to Focus on Rare Diseases | Birmingham News
BioCryst Pharmaceuticals is shutting down its Birmingham Discovery Center by end of 2026, shifting from in-house drug discovery to partnering externally for rare disease treatments—aiming for greater efficiency, growth, and innovation while thanking the team and supporting affected employees. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on public reporting.Report issues to feedback@thednn.ai. View sources & latest updates:https://sources.thednn.ai/ce10bd037a6ed5f5
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.